It also leaves you vulnerable to disease-causing bacteria, and increases the risk of conditions such as Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), obesity, diabetes, cardiovascular issues, cancer and more
Direct and Indirect Effects of GLP-1 and GIP Receptor Agonism in the Human Body 2,4,5,12 In addition to their beneficial actions in diabetes and obesity, new research suggests that incretin-based therapies may reduce inflammation in the heart, liver, kidneys, and brain
M.SweeneyD.OttawayN.et al
KLOW, for instance, contains three ingredients with anti-inflammatory rationales (BPC-157, GHK-Cu, KPV)
Bridon, ConjuChem Biotechnologies, or any associated institutions, and this information does not constitute an endorsement of any products or services